Skip to main content
NCBI home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1960 Jun;15(2):304–312. doi: 10.1111/j.1476-5381.1960.tb01249.x

The pharmacology of chymotrypsin administered by inhalation

L Golberg, L E Martin, P Sheard, C Harrison
PMCID: PMC1481930  PMID: 13850540

Abstract

The ability of chymotrypsin to reach the limits of the bronchial tree has been studied in cats receiving the enzyme by inhalation as a very fine powder. For this purpose derivatives of chymotrypsin were used which had been labelled with a fluorescent molecule or with [131I]. Quantitative measurements of the absorption and distribution of inhaled chymotrypsin- [131I] revealed a rapid removal of radioactivity from the lungs over the first 24 hr. and corresponding excretion of labelled inorganic iodide in the urine. High levels of activity were not attained in the blood or thyroid. Subcutaneous administration of labelled enzyme led to more rapid accumulation of radioactivity in the blood and thyroid. Consideration of these and other results leads to the conclusion that, while some enzyme ascends the respiratory tract by ciliary movement of mucus, a substantial part is absorbed into the lungs and the [131I] subsequently detached from it.

The changes in tidal air accompanying inhalation of labelled trypsin and chymotrypsin were followed in anaesthetized cats. Trypsin brings about a decrease in tidal air in distinctly lower doses than does chymotrypsin. Prior administration of mepyramine had an antagonistic effect, and it is suggested that the change in tidal air is essentially the result of bronchial spasm.

Full text

PDF
304

Images in this article

306FIG. 2
on p.306
307FIG. 3
on p.307

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARER G. W., NUSSER E. The part played by bronchial muscles in pulmonary reflexes. Br J Pharmacol Chemother. 1953 Sep;8(3):315–320. doi: 10.1111/j.1476-5381.1953.tb00800.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BOGNER R. L., EDELMAN A., MARTIN G. J. In vivo observations with radioactive trypsin. Arch Int Pharmacodyn Ther. 1959 Jan 1;118(1-2):122–137. [PubMed] [Google Scholar]
  3. EICHLER O., SEBENING F. [Storage of I-131 by the trachea. Corrections and supplements]. Arzneimittelforschung. 1959 Aug;9:468–470. [PubMed] [Google Scholar]
  4. HARTLEY B. S., MASSEY V. The active centre of chymotrypsin. I. Labelling with a fluorescent dye. Biochim Biophys Acta. 1956 Jul;21(1):58–70. doi: 10.1016/0006-3002(56)90093-2. [DOI] [PubMed] [Google Scholar]
  5. KONZETT H. The effects of 5-hydroxytryptamine and its antagonists on tidal air. Br J Pharmacol Chemother. 1956 Sep;11(3):289–294. doi: 10.1111/j.1476-5381.1956.tb01068.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. MARTIN G. J., BOGNER R. L., EDELMAN A. Further in vivo observations with radioactive trypsin. Am J Pharm Sci Support Public Health. 1957 Nov;129(11):386–392. [PubMed] [Google Scholar]
  7. VEALL N., PEARSON J. D., HANLEY T. The preparation of 132 I and 131 I labelled human serum albumin for clinical tracer studies. Br J Radiol. 1955 Nov;28(335):633–635. doi: 10.1259/0007-1285-28-335-633. [DOI] [PubMed] [Google Scholar]
  8. WERLE E., KEHL R., KOEBKE K. Uber Trypsin, Chymotrypsin, kallidin und Bradykinin. Biochem Z. 1950;321(3):213–220. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES